Alcon AG | ALC - Ebitda

Stock Price
50.42
Daily Change
0.81 1.63%
Monthly
-21.10%
Yearly
-31.94%
Q2 Forecast
49.42

Alcon AG reported $795M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
AstraZeneca USD 5.67B 1.29B Mar/2026
Bayer EUR 4.45B 2.49B Mar/2026
Essilor EUR 3.09B 356M Dec/2024
Fresenius EUR 951M 283M Mar/2026
Fresenius Medical Care EUR 824M 250M Mar/2026
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
GRIFOLS EUR 347.45M 210K Dec/2025
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.44B 263M Dec/2025
Novartis USD 5.3B 530M Mar/2026
Philips EUR 567M 233M Mar/2026
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 3.31B 3.65B Mar/2026
Smith & Nephew USD 796M 139M Dec/2025
UCB EUR 1.6B 570M Dec/2025